Navigation Links
Vestiage Announces Filing of Disclosure Statement with Exchange
Date:4/10/2013

Newport Beach, California (PRWEB) April 10, 2013

Vestiage, Inc., an anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium branded highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it has filed a disclosure statement known as Form 15c2-11 with the OTC Markets Exchange. The release outlines Company details for the first time to the public and clears the path for a symbol change application in the upcoming month.

“We are pleased to have executed this component of our plan to increase the visibility of the Company with market participants," stated Scott Kimball, CEO of Vestiage, Inc. "The Company is now public and we have several initiatives to execute upon in the coming months and years, including our acquisition program, expansion of distribution in multiple channels for our brands, and the beginning of our investor relations campaign. Our investor relations efforts will begin to show the investment community the power of the model we have created, the power of the team we have assembled, and the synergies of the acquisitions we are pursuing. We intend to acquire brands and integrate and leverage their management teams expertise into our business, add key advisory board members that can have true impact on our business, and grow our footprint geographically through online, direct response, and retail depending upon the brand."

The disclosure filing describes the Company's securities, the number and class of shares outstanding, names the Company's law firm and transfer agent, discusses the Company's business strategy and names the Company's Directors and Executive Officers as well as certain beneficial owners of the Company stock.

About Vestiage, Inc
Vestiage is a leading publicly traded anti-aging lifestyle company. Vestiage brands are available at http://www.LEAVEAGEBEHIND.com and address the top “in demand” anti-aging consumer concerns. The company is involved in the research, development, marketing, and sales of science-based anti-aging and longevity products. Vestiage offers premium branded science-based cosmeceuticals and nutraceuticals and is focused on the use of human stem cell, marine/ocean-and cutting edge botanically-based ingredients and science to produce highly potent and effective products with clinically proven, patented ingredients. To learn more about Vestiage products please visit http://www.LEAVEAGEBEHIND.com.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at the SEC's website (http://www.sec.gov).

Read the full story at http://www.prweb.com/releases/2013/4/prweb10608877.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage CEO Comments on Immortal Life
2. Vestiage to Partner with Skincare By Alana
3. ChanTest Announces Their Second User Meeting: Partnerships in Drug Discovery
4. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
5. Probiotic Action Announces New Edible Probiotic Trend
6. Core and More Technologies Announces the Most Comprehensive and Cost-effective Paid Search Advertising Packages Available in the Industry Today
7. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
8. Probiotic Action Announces New Use for Their Adult Acne Treatment and Explains its Beauty Benefits for Women
9. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
10. ACC Clean Energy Challenge Announces Elite Eight Plus Two, Will Vie to Reach Final Four
11. Seahorse Bioscience Announces AACR Travel Award Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):